China Nepstar Chain Drugstore (NPD) Reports Q4 EPS of RMB0.38
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/29/2026
- S&P 500 flat as higher bond yields counter tech optimism
- Anthropic prospectus shows $2T IPO ambition, warns of AI 'existential risk'
- Risk appetite remains concentrated in large-cap stocks, Citi says
- Netflix stock: Deutsche Bank gets bullish as valuation leaves room to run
- CarMax shares rise over 2% on strong earnings and revenue beat
- Salesforce agrees to acquire AI research platform Listen Labs
- Workday cuts 2.5% of workforce, revises GAAP margin outlook
- Bloom Energy shares fall on Oracle project halt
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Stocks fall as higher oil prices, Treasury yields weigh
China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2015 Financial Results
March 29, 2016 4:00 AM EDTSHENZHEN, China, March 29, 2015 /PRNewswire/ -- China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company"), a leading retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2015.
Financial Highlights
For the quarter ended December 31, 2015:
Same store sales increased by 12.5% compared to the fourth quarter of 2014 Revenue increased by 6.5% to RMB905.2 million (US$139.7 million) compared to RMB850.1 million in the fourth quarter of 2014... More